Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2000
06/15/2000CA2354232A1 Compounds and methods for treatment and diagnosis of chlamydial infection
06/15/2000CA2354189A1 Methods of inhibiting ectopic calcification
06/15/2000CA2354188A1 Cancer cell vaccine
06/15/2000CA2354142A1 Reversible aqueous ph sensitive lipidizing reagents, compositions and methods of use
06/15/2000CA2354044A1 Protein transduction system and methods of use thereof
06/15/2000CA2354026A1 Beta-1,3-galactosyltransferase homologs
06/15/2000CA2353930A1 Purification of echinocandin cyclopeptide compounds
06/15/2000CA2353797A1 Neuron-associated proteins
06/15/2000CA2353776A1 Composition and method for regulation of body weight and associated conditions
06/15/2000CA2353773A1 Cark protein and nucleic acid molecules and uses therefor
06/15/2000CA2353525A1 Drug targets in candida albicans
06/15/2000CA2353522A1 Treatment of pompe's disease
06/15/2000CA2353516A1 Cancer treatment composition and method using natural plant essential oils
06/15/2000CA2353476A1 Cancer treatment composition and method using signal transduction modulators and natural plant essential oils
06/15/2000CA2353475A1 Cancer treatment composition and method using natural plant essential oils with signal transduction modulators
06/15/2000CA2353469A1 Therapeutic agent for the suppression of snoring noises
06/15/2000CA2352740A1 Procollagen c-proteinase inhibitors
06/15/2000CA2352608A1 Heat shock genes and proteins from neisseria meningitidis, candida glabrata and aspergillus fumigatus
06/15/2000CA2352178A1 Phospholipid compositions
06/15/2000CA2351628A1 Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene
06/15/2000CA2351555A1 Method of treating thrombocytopenic purpura and hemolytic uremic syndrome
06/15/2000CA2351452A1 Methods and compositions useful for targeting activated vitronectin receptor .alpha.v.beta.3
06/15/2000CA2349404A1 Use of an immuno complex for the preparation of a therapeutic composition useful for transfecting a polynucleotide into macropinocyte cells
06/15/2000CA2342967A1 Modifying protein immunogenicity
06/14/2000EP1008604A1 Cell chemotactic factor (cctf) originating in mammalian tooth precement or cement, method for purifying the same, and novel connective tissue adhesion promoters containing the same as the active ingredient
06/14/2000EP1008603A1 Soluble polypeptides
06/14/2000EP1008352A1 Brain-protective agent
06/14/2000EP1008351A1 Carcinostatic agents
06/14/2000EP1008350A1 Stabilised antithrombin III preparation
06/14/2000EP1008349A1 Neovascularization promoters
06/14/2000EP1008342A2 Pharmaceutically active compounds and liposomes, and methods of use thereof
06/14/2000EP1007735A1 Anti-sense oligonucleotide pharmacological agents
06/14/2000EP1007729A1 COMPLEX FORMATION BETWEEN dsDNA AND OLIGOMER OF HETEROCYCLES
06/14/2000EP1007723A1 Methods for using granzymes and binding molecules thereof for treating diseases characterized by abnormal apoptosis
06/14/2000EP1007721A1 Process for preparing obesity protein analogs
06/14/2000EP1007720A1 Dendritic cell hybrids
06/14/2000EP1007717A2 Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
06/14/2000EP1007716A1 Use of lentiviral vectors for antigen presentation in dendritic cells
06/14/2000EP1007714A1 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof
06/14/2000EP1007700A1 Immunological detection of prions
06/14/2000EP1007696A1 Il-13 receptor specific chimeric proteins and uses thereof
06/14/2000EP1007695A2 Rab proteins
06/14/2000EP1007693A1 Pak kinase genes and polypeptides and methods of use thereof
06/14/2000EP1007692A2 Disease associated protein kinases
06/14/2000EP1007691A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
06/14/2000EP1007687A1 Fiv vaccine
06/14/2000EP1007686A1 Tuberculosis vaccine
06/14/2000EP1007685A2 Surface exposed proteins from chlamydia pneumoniae
06/14/2000EP1007683A1 Coffee storage proteins
06/14/2000EP1007681A1 Method of increasing the iron content of plant cells
06/14/2000EP1007680A2 Single and double chain antibodies to the egf receptor, derivatives thereof and their use
06/14/2000EP1007679A1 Recombinant human erythropoietin with advantageous glycosylation profile
06/14/2000EP1007678A1 Kringle1
06/14/2000EP1007677A2 Protease-related protein
06/14/2000EP1007676A1 High affinity immunoglobulin e receptor-like protein
06/14/2000EP1007675A1 Porcine mhc class i genes and uses thereof
06/14/2000EP1007674A1 Testis-specific transcription factor zgcl-1
06/14/2000EP1007673A1 Novel bone mineralization proteins, dna, vectors, expression systems
06/14/2000EP1007672A1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways
06/14/2000EP1007671A1 Fanconi-gen ii
06/14/2000EP1007669A1 A novel cell surface receptor for hiv retroviruses, therapeutic and diagnostic uses
06/14/2000EP1007668A1 Human pancreatitis-associated protein, pap-2
06/14/2000EP1007666A1 Neurturin receptor
06/14/2000EP1007665A1 Two human homologues of galectin-5
06/14/2000EP1007664A1 Therapies involving mutated heat shock transcription factor
06/14/2000EP1007663A2 Human proteins
06/14/2000EP1007662A1 Method for induction of apoptotic cell death in malignant cells, through reduction of the rb to apoptosis inducing proteins ratio
06/14/2000EP1007661A2 Secreted proteins and polynucleotides encoding them
06/14/2000EP1007660A2 Secreted proteins and polynucleotides encoding them
06/14/2000EP1007658A2 Mdm2-specific antisense oligonucleotides
06/14/2000EP1007657A2 Hiv-specific oligonucleotides and methods of their use
06/14/2000EP1007656A1 Modified protein kinase a-specific oligonucleotides and methods of their use
06/14/2000EP1007655A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections
06/14/2000EP1007650A1 Pca3, pca3 genes, and methods of use
06/14/2000EP1007648A1 Anti-obesity proteins
06/14/2000EP1007645A1 Human serum inducible kinase (snk)
06/14/2000EP1007643A2 1-alpha-hydroxylase
06/14/2000EP1007642A2 Disease related nucleotide kinases
06/14/2000EP1007639A1 GLUCOSE RESPONSIVE $g(b)-CELL LINE
06/14/2000EP1007632A1 Isolation of bone and cartilage precursor cells
06/14/2000EP1007569A1 STIMULATION OF AN IMMUNE RESPONSE WITH ANTIBODIES LABELED WITH THE $g(a)-GALACTOSYL EPITOPE
06/14/2000EP1007568A1 Collagen mimics
06/14/2000EP1007567A1 Epitope-bearing major histocompatibility complex class ii element/immunoglobulin chimeric molecules
06/14/2000EP1007566A2 Therapeutic use of the smr1 protein and active derivatives thereof
06/14/2000EP1007564A1 Isolated dna encoding human calcium activated potassium channel
06/14/2000EP1007563A1 Hm74a receptor
06/14/2000EP1007562A1 TUMOR NECROSIS FACTOR RECEPTOR RELATED PROTEINS TANGO-63d AND TANGO-63e
06/14/2000EP1007561A2 Novel conjugates of opioids and endogenous carriers
06/14/2000EP1007556A2 Troponin subunits and fragments useful as angiogenesis inhibitors
06/14/2000EP1007555A1 Tropoelastin derivatives
06/14/2000EP1007550A2 COMPOUNDS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF $i(EHRLICHIA) INFECTION
06/14/2000EP1007549A1 Compositions and methods for highly efficient transfection
06/14/2000EP1007548A1 Tsetse thrombin inhibitor
06/14/2000EP1007547A1 Peptides comprising a t-cell epitope specific to collagen ii
06/14/2000EP1007545A2 Cyclopeptide derivatives as adhesion inhibitors
06/14/2000EP1007544A1 Serine protease inhibitors
06/14/2000EP1007543A1 A method for stimulating red blood cell production
06/14/2000EP1007539A1 Secreted proteins and polynucleotides encoding them
06/14/2000EP1007537A1 Receptor protein designated 2f1
06/14/2000EP1007536A1 A novel human g-protein coupled receptor
1 ... 2381 2382 2383 2384 2385 2386 2387 2388 2389 2390 2391 2392 2393 2394 2395 2396 2397 2398 2399 2400 2401 ... 3163